Slate Path Capital’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.78M Hold
319,000
0.1% 41
2025
Q1
$6.53M Hold
319,000
0.12% 48
2024
Q4
$8.2M Buy
+319,000
New +$8.2M 0.15% 47